The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Alphabet Inc. Class C | Common | 02079K107 | 8,894 | 8,500 | SH | DFND | 8,500 | 0 | 0 | ||
Altaba | Common | 021346101 | 83,820 | 1,200,000 | SH | DFND | 1,200,000 | 0 | 0 | ||
Acadia Healthcare | Common | 00404A109 | 9,136 | 280,000 | SH | DFND | 280,000 | 0 | 0 | ||
Akers Biosciences | Common | 00973E102 | 138 | 1,032,000 | SH | DFND | 1,032,000 | 0 | 0 | ||
Conatus Pharmaceuticals | Common | 20600T108 | 924 | 200,000 | SH | DFND | 200,000 | 0 | 0 | ||
Crispr Therapeutics | Common | H17182108 | 190 | 8,100 | SH | DFND | 8,100 | 0 | 0 | ||
DBV Technologies | Common | 23306J101 | 738 | 30,000 | SH | DFND | 30,000 | 0 | 0 | ||
Editas Medicine | Common | 28106W103 | 194 | 6,300 | SH | DFND | 6,300 | 0 | 0 | ||
Common | 30303M102 | 1,588 | 9,000 | SH | DFND | 9,000 | 0 | 0 | |||
Fiesta Restaurant Group | Common | 31660B101 | 1,876 | 98,724 | SH | DFND | 98,724 | 0 | 0 | ||
Galectin Therapeutics | Common | 363225202 | 167 | 50,000 | SH | DFND | 50,000 | 0 | 0 | ||
Immuron Limited | ADR | 45254U101 | 53 | 10,000 | SH | DFND | 10,000 | 0 | 0 | ||
Ishares Gold Trust | ETF | 464285105 | 419 | 33,500 | SH | DFND | 33,500 | 0 | 0 | ||
Intellia Therapeutics | Common | 45826J105 | 138 | 7,200 | SH | DFND | 7,200 | 0 | 0 | ||
Jones Energy | Common | 48019R908 | 656 | 25,000 | SH | DFND | 25,000 | 0 | 0 | ||
Michael Kors | Common | G60754101 | 3,148 | 50,000 | SH | DFND | 50,000 | 0 | 0 | ||
Next Decade | Warrants | 65342K113 | 126 | 15,200 | SH | DFND | 15,200 | 0 | 0 | ||
Novocure | Common | G6674U108 | 2,020 | 100,000 | SH | DFND | 100,000 | 0 | 0 | ||
PG&E | Option | 69331C108 | 1,735 | 40,900 | SH | Call | DFND | 40,900 | 0 | 0 | |
SPDR Gold Shares ETF | ETF | 78463V107 | 319 | 1,194 | SH | DFND | 1,194 | 0 | 0 | ||
SPDR S&P 500 ETF | ETF | 78462F103 | 1,422 | 11,500 | SH | DFND | 11,500 | 0 | 0 | ||
Vanguard Scottsdale Bond Fund | ETF | 92206C870 | 489 | 5,600 | SH | DFND | 5,600 | 0 | 0 | ||
Vereit | Common | 92339V100 | 15,385 | 1,975,000 | SH | DFND | 1,975,000 | 0 | 0 | ||
Valeant Pharmaceuticals | Option | 91911K102 | 5,195 | 250,000 | SH | Put | DFND | 250,000 | 0 | 0 | |
Walmart Stores | Common | 931142103 | 548 | 5,550 | SH | DFND | 5,550 | 0 | 0 | ||
Web.com Group | Bond | 94733AAA2 | 247 | 250,000 | PRN | DFND | 250,000 | 0 | 0 |